Lipid nanoparticles for nucleic acid delivery to endothelial cells

GW Liu, EB Guzman, N Menon, RS Langer - Pharmaceutical Research, 2023 - Springer
Endothelial cells play critical roles in circulatory homeostasis and are also the gateway to
the major organs of the body. Dysfunction, injury, and gene expression profiles of these cells …

Liposomal delivery of CRISPR/Cas9

S Zhen, X Li - Cancer gene therapy, 2020 - nature.com
Liposomes are one of the most widely investigated carriers for CRISPR/Cas9 delivery. The
surface properties of liposomal carriers, including the surface charge, PEGylation, and …

The potential of RNA-based therapy for kidney diseases

T Bondue, L van den Heuvel, E Levtchenko… - Pediatric Nephrology, 2023 - Springer
Inherited kidney diseases (IKDs) are a large group of disorders affecting different nephron
segments, many of which progress towards kidney failure due to the absence of curative …

Lipid delivery systems for nucleic-acid-based-drugs: From production to clinical applications

AA Barba, S Bochicchio, A Dalmoro, G Lamberti - Pharmaceutics, 2019 - mdpi.com
In the last years the rapid development of Nucleic Acid Based Drugs (NABDs) to be used in
gene therapy has had a great impact in the medical field, holding enormous promise …

[HTML][HTML] P-selectin targeted RAGE-shRNA lipoplexes alleviate atherosclerosis-associated inflammation

CA Mocanu, EV Fuior, G Voicu, D Rebleanu… - Journal of Controlled …, 2021 - Elsevier
The receptor for advanced glycation end products (RAGE) plays a central role in the chronic
inflammatory process associated with atherosclerosis development. We aimed to develop …

[HTML][HTML] The use of liposomes functionalized with the NFL-TBS. 40–63 peptide as a targeting agent to cross the in vitro blood–brain barrier and target glioblastoma …

A Mellinger, LJ Lubitz, C Gazaille, G Leneweit… - International Journal of …, 2023 - Elsevier
Glioblastoma is the most common and aggressive brain tumor. Current treatments do not
allow to cure the patients. This is partly due to the blood–brain barrier (BBB), which limits the …

Advances in the treatment of atherosclerosis with ligand‐modified nanocarriers

X Deng, J Wang, S Yu, S Tan, T Yu, Q Xu, N Chen… - …, 2024 - Wiley Online Library
Atherosclerosis, a chronic disease associated with metabolism, poses a significant risk to
human well‐being. Currently, existing treatments for atherosclerosis lack sufficient efficiency …

CRISPR/Cas9 targeting liposomes knocked down multidrug resistance proteins in brain endothelial cells as a model to predict potential pharmacoresistance

T Yang, S Curtis, A Bai, A Young, D Derosier… - Colloids and Surfaces B …, 2023 - Elsevier
This investigation aimed to use CRISPR-Cas9 gene-editing to knock down P-glycoprotein (P-
gp) expression and then establish a feasible cell line to evaluate the potential …

Engineering aspects of lipid-based delivery systems: In vivo gene delivery, safety criteria, and translation strategies

I Eş, A Thakur, AM Khaneghah, C Foged… - Biotechnology …, 2024 - Elsevier
Defects in the genome cause genetic diseases and can be treated with gene therapy. Due to
the limitations encountered in gene delivery, lipid-based supramolecular colloidal materials …

[PDF][PDF] Modulation of biliary cancer chemo‐resistance through microRNA‐mediated rewiring of the expansion of CD133+ cells

P Carotenuto, S Hedayat, M Fassan, V Cardinale… - …, 2020 - Wiley Online Library
Background and Aims Changes in single microRNA (miRNA) expression have been
associated with chemo‐resistance in biliary tract cancers (BTCs). However, a global …